Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel Schedules in Elderly/Poor Performance NSCLC
NCT00075374Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Oct 2003
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Case Comprehensive Cancer Center. Started Oct 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00075374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075374.